Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
56.3M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
9.87M
-
Shares change
-
+9.17M
-
Total reported value, excl. options
-
$193M
-
Value change
-
+$180M
-
Number of buys
-
19
-
Number of sells
-
-1
-
Price
-
$19.57
Significant Holders of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) as of Q1 2023
21 filings reported holding OBIO - Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share as of Q1 2023.
Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.87M shares
of 56.3M outstanding shares and own 17.52% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (5.12M shares), PERCEPTIVE ADVISORS LLC (2.28M shares), BlackRock Inc. (705K shares), PRICE T ROWE ASSOCIATES INC /MD/ (681K shares), Boxer Capital, LLC (250K shares), CITADEL ADVISORS LLC (170K shares), SVB Financial Group (127K shares), GEODE CAPITAL MANAGEMENT, LLC (125K shares), VANGUARD GROUP INC (104K shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (66.6K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.